“Who on the executive team has brought a fda approved drug to market before . That has grossed over 1 billion dollars . And been distributed worldwide . If Cytodyn is going to do that , I think we need someone that has done it before . Imho.”

Let me put this in simple terms for you: if the FDA approves leronlimab for COVID19 or HIV combo therapy later this year, NP and the rest of the CYDY crew will have brought a $1 billion drug to market. The Vyera deal covers distribution for HIV and there will be a distribution deal for COVID as well, which covers the remaining bases.

My point: we don’t need a new CEO to get to revenue as leronlimab is only an approval away from profits.